This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción DEVV
Bioscience Neutraceuticals, Inc. provides organic essential oil products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Bioscience Neutraceuticals, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -99.00% |
| 3 Year Change | -99.99% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| DEVV | US Personal Products | Mercado US | |
|---|---|---|---|
| 7D | 0% | -4.6% | 0.7% |
| 1Y | -99.0% | -24.9% | 23.9% |
Rentabilidad vs. Industria: DEVV underperformed the US Personal Products industry which returned -20.9% over the past year.
Rentabilidad vs. Mercado: DEVV underperformed the US Market which returned -12.9% over the past year.
Volatilidad de los precios
| DEVV volatility | |
|---|---|
| DEVV Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: DEVV has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine DEVV's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2010 | n/a | Liang Chen | www.bestaromaoils.com |
Resumen de fundamentos de Bioscience Neutraceuticals, Inc.
| Estadísticas fundamentales de DEVV | |
|---|---|
| Capitalización bursátil | US$804.00 |
| Beneficios(TTM) | -US$626.05k |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está DEVV sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DEVV | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$626.05k |
| Beneficios | -US$626.05k |
Últimos beneficios comunicados
Dec 31, 2019
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado DEVV a largo plazo?
Ver rendimiento histórico y comparativa